{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T23:12:41Z","timestamp":1793661161267,"version":"4.5.1"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T00:00:00Z","timestamp":1602633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T00:00:00Z","timestamp":1602633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences","doi-asserted-by":"crossref","award":["37222"],"award-info":[{"award-number":["37222"]}],"id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s10875-020-00881-9","type":"journal-article","created":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T10:03:19Z","timestamp":1602669799000},"page":"76-88","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Variable Abnormalities in T and B Cell Subsets in Ataxia Telangiectasia"],"prefix":"10.1007","volume":"41","author":[{"given":"Tannaz","family":"Moeini Shad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahman","family":"Yousefi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parisa","family":"Amirifar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samaneh","family":"Delavari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Rae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parviz","family":"Kokhaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Abolhassani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asghar","family":"Aghamohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5578-6595","authenticated-orcid":false,"given":"Reza","family":"Yazdani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,14]]},"reference":[{"issue":"3","key":"881_CR1","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/pai.13020","volume":"30","author":"P Amirifar","year":"2019","unstructured":"Amirifar P, Ranjouri MR, Yazdani R, Abolhassani H, Aghamohammadi A. Ataxia-telangiectasia: a review of clinical features and molecular pathology. Pediatr Allergy Immunol. 2019;30(3):277\u201388.","journal-title":"Pediatr Allergy Immunol"},{"key":"881_CR2","unstructured":"Waldmann TA. Immunological abnormalities in ataxia-telangiectasia. In: Harnden DG, Bridges BA, editors. Ataxia Telangiectasia. Sussex, John Wiley and Sons; 1982. p. 37\u201351."},{"issue":"Supplement 2","key":"881_CR3","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1542\/peds.2005-0698SSS","volume":"116","author":"N Bobba","year":"2005","unstructured":"Bobba N, Kaplan MS. Immunodeficiency and infections in ataxia-telangiectasia. Pediatrics. 2005;116(Supplement 2):568.","journal-title":"Pediatrics"},{"issue":"1","key":"881_CR4","first-page":"29","volume":"3","author":"T Moeini Shad","year":"2020","unstructured":"Moeini Shad T, Ranjouri MR, Amirifar P. ClinicalManifestations in Iranian Ataxia telangiectasia patients. Immunol Genet J. 2020;3(1):29\u201340.","journal-title":"Immunol Genet J"},{"issue":"5","key":"881_CR5","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1469-1809.2009.00535.x","volume":"73","author":"L Chessa","year":"2009","unstructured":"Chessa L, Piane M, Magliozzi M, Torrente I, Savio C, Lulli P, et al. Founder effects for ATM gene mutations in Italian Ataxia telangiectasia families. Ann Hum Genet. 2009;73(5):532\u20139.","journal-title":"Ann Hum Genet"},{"issue":"6","key":"881_CR6","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/humu.9341","volume":"25","author":"GW Birrell","year":"2005","unstructured":"Birrell GW, Kneebone K, Nefedov M, Nefedova E, Jartsev M, Mitsui M, et al. ATM mutations, haplotype analysis, and immunological status of Russian patients with ataxia telangiectasia. Hum Mutat. 2005;25(6):593.","journal-title":"Hum Mutat"},{"issue":"6","key":"881_CR7","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/mgg3.98","volume":"2","author":"MJ Podralska","year":"2014","unstructured":"Podralska MJ, Stembalska A, \u015al\u0119zak R, Lewandowicz-Uszy\u0144ska A, Pietrucha B, Ko\u0142tan S, et al. Ten new ATM alterations in polish patients with ataxia-telangiectasia. Mol Genet Genom Med. 2014;2(6):504\u201311.","journal-title":"Mol Genet Genom Med"},{"issue":"5","key":"881_CR8","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s10875-014-0044-1","volume":"34","author":"M Kraus","year":"2014","unstructured":"Kraus M, Lev A, Simon AJ, Levran I, Nissenkorn A, Levi YB, et al. Disturbed B and T cell homeostasis and neogenesis in patients with ataxia telangiectasia. J Clin Immunol. 2014;34(5):561\u201372.","journal-title":"J Clin Immunol"},{"issue":"1","key":"881_CR9","doi-asserted-by":"crossref","first-page":"345","DOI":"10.4049\/jimmunol.164.1.345","volume":"164","author":"C Chao","year":"2000","unstructured":"Chao C, Yang EM, Xu Y. Rescue of defective T cell development and function in Atm\u2212\/\u2212 mice by a functional TCR\u03b1\u03b2 transgene. J Immunol. 2000;164(1):345\u20139.","journal-title":"J Immunol"},{"issue":"5","key":"881_CR10","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1182\/blood.V99.5.1544","volume":"99","author":"K Warnatz","year":"2002","unstructured":"Warnatz K, Denz A, Drager R, Braun M, Groth C, Wolff-Vorbeck G, et al. Severe deficiency of switched memory B cells (CD27+ IgM\u2212 IgD\u2212) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. Blood. 2002;99(5):1544\u201351.","journal-title":"Blood"},{"issue":"5","key":"881_CR11","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1023\/A:1025373601374","volume":"23","author":"B Piqueras","year":"2003","unstructured":"Piqueras B, Lavenu-Bombled C, Galicier L, Bergeronvan der Cruyssen F, Mouthon L, Chevret S, et al. Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects. J Clin Immunol. 2003;23(5):385\u2013400.","journal-title":"J Clin Immunol"},{"issue":"1","key":"881_CR12","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1182\/blood-2007-06-091744","volume":"111","author":"C Wehr","year":"2008","unstructured":"Wehr C, Kivioja T, Schmitt C, Ferry B, Witte T, Eren E, et al. The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood. 2008;111(1):77\u201385.","journal-title":"Blood"},{"key":"881_CR13","doi-asserted-by":"crossref","unstructured":"Bichuetti-Silva DC, Pereira CTM, Ferreira N, Salom\u00e3o R, Brunialti MKC, Carvalho BC. Transitional B cells and CD21low in patients with ataxia-telangiectasia. World Allergy Organ J. 2015;8 Suppl 1:A63.","DOI":"10.1186\/1939-4551-8-S1-A63"},{"issue":"4","key":"881_CR14","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1515\/labmed-2016-0018","volume":"40","author":"A De Stefano","year":"2016","unstructured":"De Stefano A, Boldt A, Schmiedel L, Sack U, Kentouche K. Flow cytometry as an important tool in the diagnosis of immunodeficiencies demonstrated in a patient with ataxia-telangiectasia. Laboratoriumsmedizin. 2016;40(4):255\u201361.","journal-title":"Laboratoriumsmedizin"},{"issue":"5","key":"881_CR15","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s10875-017-0405-7","volume":"37","author":"T Takashima","year":"2017","unstructured":"Takashima T, Okamura M, Yeh T-W, Okano T, Yamashita M, Tanaka K, et al. Multicolor flow cytometry for the diagnosis of primary immunodeficiency diseases. J Clin Immunol. 2017;37(5):486\u201395.","journal-title":"J Clin Immunol"},{"issue":"5","key":"881_CR16","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.aller.2017.09.031","volume":"46","author":"C Pereira","year":"2018","unstructured":"Pereira C, Bichuetti-Silva D, da Mota N, Salomao R, Brunialti M, Costa-Carvalho B. B-cell subsets imbalance and reduced expression of CD40 in ataxia-telangiectasia patients. Allergol Immunopathol. 2018;46(5):438\u201346.","journal-title":"Allergol Immunopathol"},{"issue":"1","key":"881_CR17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1089\/ped.2017.0788","volume":"31","author":"AS Sasihuseyinoglu","year":"2018","unstructured":"Sasihuseyinoglu AS, Y\u0131lmaz M, Bisgin A, Dogruel D, Altintas DU, Duyuler G, et al. Ataxia-telangiectasia clinical and laboratory features: single center results. Pediatr Allergy Immunol Pulmonol. 2018;31(1):9\u201314.","journal-title":"Pediatr Allergy Immunol Pulmonol"},{"key":"881_CR18","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/bmb\/ldm012","volume":"81\u201382","author":"MF Lavin","year":"2007","unstructured":"Lavin MF, Gueven N, Bottle S, Gatti RA. Current and potential therapeutic strategies for the treatment of ataxia-telangiectasia. Br Med Bull. 2007;81\u201382:129\u201347.","journal-title":"Br Med Bull"},{"issue":"4","key":"881_CR19","first-page":"255","volume":"40","author":"A De Stefano","year":"2016","unstructured":"De Stefano A, Boldt A, Schmiedel L, Sack U, Kentouche K. Flow cytometry as an important tool in the diagnosis of immunodeficiencies demonstrated in a patient with ataxia-telangiectasia. J Lab Med. 2016;40(4):255\u201361.","journal-title":"J Lab Med"},{"issue":"7","key":"881_CR20","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1007\/s10875-018-0556-1","volume":"38","author":"H Abolhassani","year":"2018","unstructured":"Abolhassani H, Kiaee F, Tavakol M, Chavoshzadeh Z, Mahdaviani SA, Momen T, et al. Fourth update on the Iranian National Registry of Primary Immunodeficiencies: integration of molecular diagnosis. J Clin Immunol. 2018;38(7):816\u201332.","journal-title":"J Clin Immunol"},{"issue":"1","key":"881_CR21","first-page":"1","volume":"2","author":"H Abolhassani","year":"2019","unstructured":"Abolhassani H, Tavakol M, Chavoshzadeh Z, Mahdaviani SA, Momen T, Yazdani R, et al. National consensus on diagnosis and management guidelines for primary immunodeficiency. Immunol Genet J. 2019;2(1):1\u201343.","journal-title":"Immunol Genet J"},{"key":"881_CR22","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/j.jaip.2019.02.004","volume":"7","author":"MG Seidel","year":"2019","unstructured":"Seidel MG, Kindle G, Gathmann B, Quinti I, Buckland M, van Montfrans J, et al. The European Society for Immunodeficiencies (ESID) registry working definitions for the clinical diagnosis of inborn errors of immunity. J Allergy Clin Immunol Pract. 2019;7:1763\u201370.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"881_CR23","unstructured":"Amirifar P, Mozdarani H, Yazdani R, Kiaei F, Moeini Shad T, Shahkarami S, et al. Effect of class switch recombination defect on the phenotype of ataxia-telangiectasia patients. Immunol Investig. 2020;1\u201315."},{"issue":"6","key":"881_CR24","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/pr.2016.19","volume":"79","author":"A Nissenkorn","year":"2016","unstructured":"Nissenkorn A, Levy-Shraga Y, Banet-Levi Y, Lahad A, Sarouk I, Modan-Moses D. Endocrine abnormalities in ataxia telangiectasia: findings from a national cohort. Pediatr Res. 2016;79(6):889\u201394.","journal-title":"Pediatr Res"},{"issue":"1","key":"881_CR25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.pediatrneurol.2007.03.002","volume":"37","author":"M Moin","year":"2007","unstructured":"Moin M, Aghamohammadi A, Kouhi A, Tavassoli S, Rezaei N, Ghaffari S-R, et al. Ataxia-telangiectasia in Iran: clinical and laboratory features of 104 patients. Pediatr Neurol. 2007;37(1):21\u20138.","journal-title":"Pediatr Neurol"},{"key":"881_CR26","unstructured":"Alyasin S, Esmaeilzadeh H, Ebrahimi N, Nabavizadeh SH, Nemati H. Clinical presentation of ataxia-telangiectasia. Arch Iran Med. 2019;22(12):682\u2013686."},{"key":"881_CR27","unstructured":"Jozwiak S, Janniger CK. Ataxia-telangiectasia. 2006. E-medicine from the the web. http:\/\/www.emedicine.com\/derm\/tpic691.htm."},{"issue":"18","key":"881_CR28","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJM196910302811818","volume":"281","author":"M Ament","year":"1969","unstructured":"Ament M. Respiratory complications of ataxia-telangiectasia. N Engl J Med. 1969;281(18):1019.","journal-title":"N Engl J Med"},{"issue":"7","key":"881_CR29","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/j.1651-2227.2007.00338.x","volume":"96","author":"L Bott","year":"2007","unstructured":"Bott L, Lebreton J, Thumerelle C, Cuvellier J, Deschildre A, Sardet A. Lung disease in ataxia-telangiectasia. Acta Paediatr. 2007;96(7):1021\u20134.","journal-title":"Acta Paediatr"},{"issue":"4","key":"881_CR30","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jpeds.2003.12.046","volume":"144","author":"A Nowak-Wegrzyn","year":"2004","unstructured":"Nowak-Wegrzyn A, Crawford TO, Winkelstein JA, Carson KA, Lederman HM. Immunodeficiency and infections in ataxia-telangiectasia. J Pediatr. 2004;144(4):505\u201311.","journal-title":"J Pediatr"},{"key":"881_CR31","unstructured":"Canny G, Roifman C, Weitzman S, Braudo M, Levison H. A pulmonary infiltrate in a child with ataxia telangiectasia. Ann Allergy. 1988;61(6):422\u20133, 466\u20138."},{"issue":"5","key":"881_CR32","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.jaci.2013.01.053","volume":"131","author":"GJ Driessen","year":"2013","unstructured":"Driessen GJ, IJspeert H, Weemaes CM, Haraldsson \u00c1, Trip M, Warris A, et al. Antibody deficiency in patients with ataxia telangiectasia is caused by disturbed B-and T-cell homeostasis and reduced immune repertoire diversity. J Allergy Clin Immunol. 2013;131(5):1367\u201375. e9.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"881_CR33","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.4049\/jimmunol.181.4.2620","volume":"181","author":"AL Bredemeyer","year":"2008","unstructured":"Bredemeyer AL, Huang C-Y, Walker LM, Bassing CH, Sleckman BP. Aberrant V (D) J recombination in ataxia telangiectasia mutated-deficient lymphocytes is dependent on nonhomologous DNA end joining. J Immunol. 2008;181(4):2620\u20135.","journal-title":"J Immunol"},{"issue":"10","key":"881_CR34","doi-asserted-by":"crossref","first-page":"5982","DOI":"10.4049\/jimmunol.0801859","volume":"182","author":"A Palanichamy","year":"2009","unstructured":"Palanichamy A, Barnard J, Zheng B, Owen T, Quach T, Wei C, et al. Novel human transitional B cell populations revealed by B cell depletion therapy. J Immunol. 2009;182(10):5982\u201393.","journal-title":"J Immunol"},{"issue":"1","key":"881_CR35","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nri2217","volume":"8","author":"U Klein","year":"2008","unstructured":"Klein U, Dalla-Favera R. Germinal centres: role in B-cell physiology and malignancy. Nat Rev Immunol. 2008;8(1):22\u201333.","journal-title":"Nat Rev Immunol"},{"issue":"24","key":"881_CR36","doi-asserted-by":"crossref","first-page":"5026","DOI":"10.1182\/blood-2009-09-243071","volume":"115","author":"I Isnardi","year":"2010","unstructured":"Isnardi I, Ng YS, Menard L, Meyers G, Saadoun D, Srdanovic I, et al. Complement receptor 2\/CD21- human naive B cells contain mostly autoreactive unresponsive clones. Blood. 2010;115(24):5026\u201336.","journal-title":"Blood"},{"issue":"32","key":"881_CR37","doi-asserted-by":"crossref","first-page":"13451","DOI":"10.1073\/pnas.0901984106","volume":"106","author":"M Rakhmanov","year":"2009","unstructured":"Rakhmanov M, Keller B, Gutenberger S, Foerster C, Hoenig M, Driessen G, et al. Circulating CD21low B cells in common variable immunodeficiency resemble tissue homing, innate-like B cells. Proc Natl Acad Sci U S A. 2009;106(32):13451\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"18","key":"881_CR38","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1182\/blood-2010-05-285585","volume":"116","author":"M Rakhmanov","year":"2010","unstructured":"Rakhmanov M, Gutenberger S, Keller B, Schlesier M, Peter HH, Warnatz K. CD21low B cells in common variable immunodeficiency do not show defects in receptor editing, but resemble tissue-like memory B cells. Blood. 2010;116(18):3682\u20133.","journal-title":"Blood"},{"issue":"22","key":"881_CR39","doi-asserted-by":"crossref","first-page":"5977","DOI":"10.1182\/blood-2011-09-373969","volume":"118","author":"N Romberg","year":"2011","unstructured":"Romberg N, Ng Y-S, Cunningham-Rundles C, Meffre E. Response: common variable immunodeficiency patients with increased CD21\u2212\/lo B cells suffer from altered receptor editing and defective central B-cell tolerance. Blood. 2011;118(22):5977\u20138.","journal-title":"Blood"},{"issue":"12","key":"881_CR40","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1182\/blood-2004-01-0346","volume":"104","author":"S Weller","year":"2004","unstructured":"Weller S, Braun MC, Tan BK, Rosenwald A, Cordier C, Conley ME, et al. Human blood IgM \u201cmemory\u201d B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire. Blood. 2004;104(12):3647\u201354.","journal-title":"Blood"},{"issue":"4","key":"881_CR41","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1172\/JCI3409","volume":"102","author":"K Agematsu","year":"1998","unstructured":"Agematsu K, Nagumo H, Shinozaki K, Hokibara S, Yasui K, Terada K, et al. Absence of IgD-CD27 (+) memory B cell population in X-linked hyper-IgM syndrome. J Clin Invest. 1998;102(4):853\u201360.","journal-title":"J Clin Invest"},{"issue":"3","key":"881_CR42","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1073\/pnas.98.3.1166","volume":"98","author":"S Weller","year":"2001","unstructured":"Weller S, Faili A, Garcia C, Braun MC, Le Deist F, de Saint BG, et al. CD40-CD40L independent Ig gene hypermutation suggests a second B cell diversification pathway in humans. Proc Natl Acad Sci. 2001;98(3):1166\u201370.","journal-title":"Proc Natl Acad Sci"},{"issue":"3","key":"881_CR43","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/sji.12339","volume":"82","author":"K Thorarinsdottir","year":"2015","unstructured":"Thorarinsdottir K, Camponeschi A, Gjertsson I, M\u00e5rtensson IL. CD 21\u2212\/low B cells: a snapshot of a unique B cell subset in health and disease. Scand J Immunol. 2015;82(3):254\u201361.","journal-title":"Scand J Immunol"},{"issue":"2","key":"881_CR44","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.aller.2016.07.001","volume":"45","author":"R Yazdani","year":"2017","unstructured":"Yazdani R, Seify R, Ganjalikhani-Hakemi M, Abolhassani H, Eskandari N, Golsaz-Shirazi F, et al. Comparison of various classifications for patients with common variable immunodeficiency (CVID) using measurement of B-cell subsets. Allergol Immunopathol (Madr). 2017;45(2):183\u201392.","journal-title":"Allergol Immunopathol (Madr)"},{"issue":"9","key":"881_CR45","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.autrev.2016.07.011","volume":"15","author":"G Patuzzo","year":"2016","unstructured":"Patuzzo G, Barbieri A, Tinazzi E, Veneri D, Argentino G, Moretta F, et al. Autoimmunity and infection in common variable immunodeficiency (CVID). Autoimmun Rev. 2016;15(9):877\u201382.","journal-title":"Autoimmun Rev"},{"issue":"2","key":"881_CR46","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1172\/JCI110768","volume":"71","author":"T Waldmann","year":"1983","unstructured":"Waldmann T, Broder S, Goldman C, Frost K, Korsmeyer S, Medici M. Disorders of B cells and helper T cells in the pathogenesis of the immunoglobulin deficiency of patients with ataxia telangiectasia. J Clin Invest. 1983;71(2):282\u201395.","journal-title":"J Clin Invest"},{"issue":"9","key":"881_CR47","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0167-5699(89)90087-X","volume":"10","author":"RD Peterson","year":"1989","unstructured":"Peterson RD, Funkhouser JD. Speculations on ataxia-telangiectasia: defective regulation of the immunoglobulin gene superfamily. Immunol Today. 1989;10(9):313\u20135.","journal-title":"Immunol Today"},{"issue":"7","key":"881_CR48","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1096\/fj.00-0601com","volume":"15","author":"M Yan","year":"2001","unstructured":"Yan M, Qiang W, Liu N, Shen J, Lynn WS, Wong PK. The ataxia-telangiectasia gene product may modulate DNA turnover and control cell fate by regulating cellular redox in lymphocytes. FASEB J. 2001;15(7):1132\u20138.","journal-title":"FASEB J"},{"issue":"1","key":"881_CR49","doi-asserted-by":"crossref","first-page":"261","DOI":"10.4049\/jimmunol.1101909","volume":"189","author":"EF Carney","year":"2012","unstructured":"Carney EF, Srinivasan V, Moss PA, Taylor AM. Classical ataxia telangiectasia patients have a congenitally aged immune system with high expression of CD95. J Immunol. 2012;189(1):261\u20138.","journal-title":"J Immunol"},{"issue":"3","key":"881_CR50","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/acel.12191","volume":"13","author":"SK Garg","year":"2014","unstructured":"Garg SK, Delaney C, Toubai T, Ghosh A, Reddy P, Banerjee R, et al. Aging is associated with increased regulatory T-cell function. Aging Cell. 2014;13(3):441\u20138.","journal-title":"Aging Cell"},{"issue":"2","key":"881_CR51","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1159\/000355303","volume":"60","author":"A Jagger","year":"2014","unstructured":"Jagger A, Shimojima Y, Goronzy JJ, Weyand CM. Regulatory T cells and the immune aging process: a mini-review. Gerontology. 2014;60(2):130\u20137.","journal-title":"Gerontology"},{"key":"881_CR52","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.arr.2016.05.002","volume":"33","author":"Y Shiloh","year":"2017","unstructured":"Shiloh Y, Lederman HM. Ataxia-telangiectasia (AT): an emerging dimension of premature ageing. Ageing Res Rev. 2017;33:76\u201388.","journal-title":"Ageing Res Rev"},{"issue":"1","key":"881_CR53","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.clim.2011.03.007","volume":"140","author":"AR Exley","year":"2011","unstructured":"Exley AR, Buckenham S, Hodges E, Hallam R, Byrd P, Last J, et al. Premature ageing of the immune system underlies immunodeficiency in ataxia telangiectasia. Clin Immunol. 2011;140(1):26\u201336.","journal-title":"Clin Immunol"},{"issue":"2","key":"881_CR54","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/cyto.a.21010","volume":"79","author":"M Roederer","year":"2011","unstructured":"Roederer M. Interpretation of cellular proliferation data: avoid the panglossian. Cytometry Part A. 2011;79(2):95\u2013101.","journal-title":"Cytometry Part A"},{"key":"881_CR55","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.3389\/fimmu.2017.01870","volume":"8","author":"A Ten Brinke","year":"2017","unstructured":"Ten Brinke A, Marek-Trzonkowska N, Mansilla MJ, Turksma AW, Piekarska K, Iwaszkiewicz-Grze\u015b D, et al. Monitoring T-cell responses in translational studies: optimization of dye-based proliferation assay for evaluation of antigen-specific responses. Front Immunol. 2017;8:1870.","journal-title":"Front Immunol"},{"issue":"8","key":"881_CR56","doi-asserted-by":"crossref","first-page":"4757","DOI":"10.4049\/jimmunol.178.8.4757","volume":"178","author":"J Bagley","year":"2007","unstructured":"Bagley J, Singh G, Iacomini J. Regulation of oxidative stress responses by ataxia-telangiectasia mutated is required for T cell proliferation. J Immunol. 2007;178(8):4757\u201363.","journal-title":"J Immunol"},{"issue":"2","key":"881_CR57","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S1074-7613(00)80605-6","volume":"9","author":"JJ Bird","year":"1998","unstructured":"Bird JJ, Brown DR, Mullen AC, Moskowitz NH, Mahowald MA, Sider JR, et al. Helper T cell differentiation is controlled by the cell cycle. Immunity. 1998;9(2):229\u201337.","journal-title":"Immunity"},{"issue":"2","key":"881_CR58","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/immu.200310003","volume":"33","author":"CG Vinuesa","year":"2003","unstructured":"Vinuesa CG, Sze DMY, Cook MC, Toellner KM, Klaus GG, Ball J, et al. Recirculating and germinal center B cells differentiate into cells responsive to polysaccharide antigens. Eur J Immunol. 2003;33(2):297\u2013305.","journal-title":"Eur J Immunol"},{"issue":"2","key":"881_CR59","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jaci.2004.10.048","volume":"115","author":"R Carsetti","year":"2005","unstructured":"Carsetti R, Rosado MM, Donnanno S, Guazzi V, Soresina A, Meini A, et al. The loss of IgM memory B cells correlates with clinical disease in common variable immunodeficiency. J Allergy Clin Immunol. 2005;115(2):412\u20137.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"881_CR60","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1189\/jlb.0312117","volume":"93","author":"JN Siebert","year":"2013","unstructured":"Siebert JN, AG LH, Grillet S, Delhumeau C, Siegrist CA, Posfay-Barbe KM. Memory B cell compartment constitution and susceptibility to recurrent lower respiratory tract infections in young children. J Leukoc Biol. 2013;93(6):951\u201362.","journal-title":"J Leukoc Biol"},{"issue":"8","key":"881_CR61","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/infdis\/jiv208","volume":"212","author":"NV Palkola","year":"2015","unstructured":"Palkola NV, Pakkanen SH, Kantele JM, Pakarinen L, Puohiniemi R, Kantele A. Differences in homing potentials of Streptococcus pneumoniae\u2013specific plasmablasts in pneumococcal pneumonia and after pneumococcal polysaccharide and pneumococcal conjugate vaccinations. J Infect Dis. 2015;212(8):1279\u201387.","journal-title":"J Infect Dis"},{"key":"881_CR62","doi-asserted-by":"crossref","unstructured":"Neill DR, Fernandes VE, Wisby L, Haynes AR, Ferreira DM, Laher A, et al. T regulatory cells control susceptibility to invasive pneumococcal pneumonia in mice. PLoS Pathog. 2012;8(4):e1002660.","DOI":"10.1371\/journal.ppat.1002660"},{"issue":"9","key":"881_CR63","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1084\/jem.20041162","volume":"200","author":"B Reina-San-Martin","year":"2004","unstructured":"Reina-San-Martin B, Chen HT, Nussenzweig A, Nussenzweig MC. ATM is required for efficient recombination between immunoglobulin switch regions. J Exp Med. 2004;200(9):1103\u201310.","journal-title":"J Exp Med"},{"issue":"9","key":"881_CR64","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/ni.1914","volume":"11","author":"B He","year":"2010","unstructured":"He B, Santamaria R, Xu W, Cols M, Chen K, Puga I, et al. The transmembrane activator TACI triggers immunoglobulin class switching by activating B cells through the adaptor MyD88. Nat Immunol. 2010;11(9):836\u201345.","journal-title":"Nat Immunol"},{"issue":"1","key":"881_CR65","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1080\/15321819.2014.891525","volume":"36","author":"P Mohammadinejad","year":"2015","unstructured":"Mohammadinejad P, Abolhassani H, Aghamohammadi A, Pourhamdi S, Ghosh S, Sadeghi B, et al. Class switch recombination process in ataxia telangiectasia patients with elevated serum levels of IgM. J Immunoass Immunochem. 2015;36(1):16\u201326.","journal-title":"J Immunoass Immunochem"},{"key":"881_CR66","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.4049\/jimmunol.181.3.1767","volume":"181","author":"W Malefyt","year":"2008","unstructured":"Malefyt W. IgA by human naive B cells is differentially IL-21-induced isotype switching to IgG and IL-21-induced isotype switching to IgG and IgA by human naive B cells is differentially regulated by IL-4 1. J Immunol Ref. 2008;181:1767\u201379.","journal-title":"J Immunol Ref"},{"issue":"3","key":"881_CR67","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/eji.200425848","volume":"35","author":"SR Park","year":"2005","unstructured":"Park SR, Seo GY, Choi AJ, Stavnezer J, Kim PH. Analysis of transforming growth factor-\u03b21-induced Ig germ-line \u03b32b transcription and its implication for IgA isotype switching. Eur J Immunol. 2005;35(3):946\u201356.","journal-title":"Eur J Immunol"},{"issue":"5","key":"881_CR68","first-page":"442","volume":"20","author":"A Aghamohammadi","year":"2010","unstructured":"Aghamohammadi A, Imai K, Moazzami K, Abolhassani H, Tabatabaeiyan M, Parvaneh N, et al. 14 Ataxia-telangiectasia in a patient presenting with hyperimmunoglobulin M syndrome. J Investig Allergol Clin Immunol. 2010;20(5):442\u20135.","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"5","key":"881_CR69","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1080\/1744666X.2017.1292131","volume":"13","author":"S Ghiasy","year":"2017","unstructured":"Ghiasy S, Parvaneh L, Azizi G, Sadri G, Zaki Dizaji M, Abolhassani H, et al. The clinical significance of complete class switching defect in Ataxia telangiectasia patients. Expert Rev Clin Immunol. 2017;13(5):499\u2013505.","journal-title":"Expert Rev Clin Immunol"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-020-00881-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-020-00881-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-020-00881-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,14]],"date-time":"2021-10-14T01:05:27Z","timestamp":1634173527000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-020-00881-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,14]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["881"],"URL":"https:\/\/doi.org\/10.1007\/s10875-020-00881-9","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,14]]},"assertion":[{"value":"21 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}